Cited by 80Vagus Nerve Stimulation ResearchSchizophrenia research and treatmentElectroconvulsive Therapy Studies

Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study

Hasan, Alkomiet, Wolff-Menzler, Claus, Pfeiffer, Sebastian, Falkai, Peter, Weidinger, Elif, Jobst, Andrea, Hoell, Imke, Malchow, Berend +5 more·2015·European Archives of Psychiatry and Clinical Neuroscience

Abstract

Despite many pharmacological and psychosocial treatment options, schizophrenia remains a debilitating disorder. Thus, new treatment strategies rooted in the pathophysiology of the disorder are needed. Recently, vagus nerve stimulation (VNS) has been proposed as a potential treatment option for various neuropsychiatric disorders including schizophrenia. The objective of this study was to investigate for the first time the feasibility, safety and efficacy of transcutaneous VNS in stable schizophrenia. A bicentric randomized, sham-controlled, double-blind trial was conducted from 2010 to 2012. Twenty schizophrenia patients were randomly assigned to one of two treatment groups. The first group (active tVNS) received daily active stimulation of the left auricle for 26 weeks. The second group (sham tVNS) received daily sham stimulation for 12 weeks followed by 14 weeks of active stimulation. Primary outcome was defined as change in the Positive and Negative Symptom Scale total score between baseline and week 12. Various other secondary measures were assessed to investigate safety and efficacy. The intervention was well tolerated with no relevant adverse effects. We could not observe a statistically significant difference in the improvement of schizophrenia psychopathology during the observation period. Neither psychopathological and neurocognitive measures nor safety measures showed significant differences between study groups. Application of tVNS was well tolerated, but did not improve schizophrenia symptoms in our 26-week trial. While unsatisfactory compliance questions the feasibility of patient-controlled neurostimulation in schizophrenia, the overall pattern of symptom change might warrant further investigations in this population.

Integrity signals

Registry

Crossref · 10.1007/s00406-015-0618-9

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • To date, only one small pilot study has employed VNS in schizophrenia and showed the intervention was well tolerated with an overall trend towards improved schizophrenia symptoms; however, compliance was low which questions the feasibility of a patient-controlled neurostimulation intervention.

    “To date, only one small pilot study has employed VNS in SCZ and showed the intervention was well tolerated with an overall trend towards improved SCZ symptoms; however, compliance was low which questions the feasibility of a patient-controlled neurostimulation intervention112.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hasan, A., Wolff-Menzler, C., Pfeiffer, S., Falkai, P., Weidinger, E., Jobst, A., Hoell, I., Malchow, B., Yeganeh-Doost, P., Strube, W., Quast, S., Müller, N., & Wobrock, T.
Affiliations
  • Ludwig-Maximilians-Universität München (DE)
  • University of Göttingen (DE)
Corresponding author
Hasan, Alkomiet
Venue
European Archives of Psychiatry and Clinical Neuroscience
Published
2015-07-26
Volume
265
Issue
7
Pages
589-600
ISSN
  • 0003-9373 (ISSN-L)
  • 0940-1334
  • 1433-8491
OpenAlex
W1921350334
Cited by
80
References
54
Citations by year
2026: 1 · 2025: 10 · 2024: 10 · 2023: 8 · 2022: 10 · 2021: 12 · 2020: 11 · 2019: 2 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 4
FWCI
2.84
Type
journal article
Language
en
Open access
closed
Locations
  • European Archives of Psychiatry and Clinical Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • GRO (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
  • OPUS (Augsburg University) (submittedVersion)
Funders
CerboMed GmbH
Topics
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
transcutaneous vagus nerve stimulation, schizophrenia, auricular stimulation, neuromodulation, treatment efficacy, safety and tolerability, PANSS, medication adherence, neuropsychological outcomes
MeSH terms
Adult, Double-Blind Method, Transcutaneous Electric Nerve Stimulation, Female, Humans, Male, Middle Aged, Pilot Projects, Schizophrenia, Schizophrenic Psychology, Treatment Outcome, Cross-Over Studies, Vagus Nerve Stimulation, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review